Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Board Member Increases Shareholding in iZafe Group
Healthcare & PharmaceuticalCompany Update

Board Member Increases Shareholding in iZafe Group

November 28, 2025 3:45 AM

iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) announces that Board Member Anna Håkansson on 27 November 2025 increased her shareholding in the company through the acquisition of 150,000 shares at a price of SEK 0.69 per share. The shares were acquired through her wholly owned company.The purchase follows an additional acquisition of 100,000 shares made in October. After the latest transaction, Anna Håkansson's total holding, via her...

Read more
Thanksgiving Wishes to the DEA's Anti Cannabis Holdouts - And Gently Suggests They Spend a Moment Thinking About Patients Waiting for Legal Medicine
Healthcare & PharmaceuticalCompany Update

Thanksgiving Wishes to the DEA's Anti Cannabis Holdouts - And Gently Suggests They Spend a Moment Thinking About Patients Waiting for Legal Medicine

November 27, 2025 3:00 PM

MMJ International Holdings Extends Warm Thanksgiving Wishes to DEA's Anti-Cannabis Holdouts - And Encourages a Moment of Reflection for Patients Still Waiting for Federally Legal Medicine MMJ International Holdings, developer of the nation's fully federally compliant, natural cannabis-derived pharmaceutical for Huntington's Disease and Multiple Sclerosis, today extends a sincere Happy Thanksgiving to the small but deeply entrenched group of DEA...

Read more
Dr. Ariel Rad Spotlight Feature Highlights a Call for Higher Standards in Aesthetic Medicine
Healthcare & PharmaceuticalCompany Update

Dr. Ariel Rad Spotlight Feature Highlights a Call for Higher Standards in Aesthetic Medicine

November 27, 2025 12:30 PM

Following his recent in-depth spotlight feature, acclaimed plastic surgeon Dr. Ariel N. Rad is using the moment to raise awareness around a growing concern in aesthetic medicine: the rapid rise of non-evidence-based treatments, unqualified providers, and social-media-driven trends that can put patients at risk. The interview, which chronicles Dr. Rad's two decades of clinical experience and the evolution of SHERBER+RAD - the integrated...

Read more
Idris Nechirvan Barzani Brings Clean Power to Kurdish Village Gassed by Saddam
Healthcare & PharmaceuticalCompany Update

Idris Nechirvan Barzani Brings Clean Power to Kurdish Village Gassed by Saddam

November 27, 2025 11:55 AM

Thirty-eight years after Iraqi forces dropped chemical weapons on Sheikh Wasan village, killing 211 civilians - mostly women, children and elderly - the same streets are now lit by clean, off-grid solar energy.The transformation is the work of the Rwanga Foundation and its founder, Idris Nechirvan Barzani, a young Kurdish businessman and philanthropist who has quietly become one of the region's most active advocates for renewable energy in...

Read more
Umbrella Labs Announces Forthcoming Retatrutide Endocrine Dynamics Research Program To Advance Mechanistic Non-Clinical Science
Healthcare & PharmaceuticalCompany Update

Umbrella Labs Announces Forthcoming Retatrutide Endocrine Dynamics Research Program To Advance Mechanistic Non-Clinical Science

November 27, 2025 8:00 AM

Umbrella Labs today announced the development of a multi-phase, non-clinical research program centered on Retatrutide (LY-3437943), designed to characterize peptide behavior, assay performance, and endocrine-signaling dynamics in laboratory models with a level of rigor typically reserved for peer-reviewed translational work. The initiative, internally termed the Retatrutide Endocrine Dynamics Framework (REDF), will combine analytical chemistry,...

Read more
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice
Healthcare & PharmaceuticalCompany Update

Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice

November 27, 2025 3:45 AM

Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") today announced that it has received a notification letter from the Nasdaq Listing Qualifications Staff (the "Staff") indicating that the Company is not in compliance with Nasdaq Listing Rules 5550(b)(1) (minimum stockholders' equity) and 5250(c)(1) (timely filing of periodic reports).The Staff determined that, based on the stockholders' equity reported in the Company's Transition...

Read more
Halsten Stride Introduces Advanced Light-Therapy Support Designed To Help Women Manage Persistent Menopausal Hip Discomfort Effectively
Healthcare & PharmaceuticalCompany Update

Halsten Stride Introduces Advanced Light-Therapy Support Designed To Help Women Manage Persistent Menopausal Hip Discomfort Effectively

November 27, 2025 2:40 AM

Halsten has announced the introduction of the Halsten Stride, a light-therapy wearable developed to address outer-hip tendon discomfort commonly experienced during and after menopause. The Halsten Stride has been engineered for menopausal and postmenopausal women who are seeking structured, at-home support for tendon-related hip challenges associated with hormonal transitions. Hip discomfort linked to menopause remains a frequently overlooked...

Read more
IRLAB Participates in Redeye Technology & Life Science Day on December 3, 2025
Healthcare & PharmaceuticalCompany Update

IRLAB Participates in Redeye Technology & Life Science Day on December 3, 2025

November 27, 2025 1:30 AM

IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will present at the Redeye Technology & Life Science Day 2025 on Wednesday, December 3, 2025, in Stockholm, Sweden.Kristina Torfgård, CEO, and Nicholas Waters, EVP and Head of R&D, will participate in the event, delivering a 2-minute pitch followed by a Q&A session at 15:40 CET on December...

Read more
GLG Life Tech Corporation Reports 2025 Third Quarter Financial Results
Healthcare & PharmaceuticalCompany Update

GLG Life Tech Corporation Reports 2025 Third Quarter Financial Results

November 26, 2025 8:00 PM

GLG Life Tech Corporation (NEX:GLG.H) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and nine months ended September 30, 2025. The complete set of financial statements and management discussion and analysis are available on SEDAR and on the Company's website at www.glglifetech.com.FINANCIAL SUMMARYThe Company...

Read more
Zealthy Under Review: The 2025 Doctor-Led GLP-1 Weight Loss Program That's Changing the Industry
Healthcare & PharmaceuticalCompany Update

Zealthy Under Review: The 2025 Doctor-Led GLP-1 Weight Loss Program That's Changing the Industry

November 26, 2025 7:10 PM

Is the future of weight loss found in an app? As GLP-1 medications like Ozempic and Wegovy continue to reshape our understanding of metabolic health, a new generation of telehealth platforms is stepping forward to make these treatments more accessible. Leading the charge is Zealthy, a company redefining what it means to deliver comprehensive, patient-first obesity care in the digital age.Unlike traditional telehealth providers, Zealthy's...

Read more
First Care Medical Clinic Recognized as the Best Primary & Urgent Care Clinic Charlotte NC for 2025
Healthcare & PharmaceuticalProduct Announcements

First Care Medical Clinic Recognized as the Best Primary & Urgent Care Clinic Charlotte NC for 2025

November 26, 2025 3:30 PM

First Care Medical Clinic is proud to announce its recognition as the Best Primary & Urgent Care Clinic in Charlotte, NC for 2025 by leading healthcare and patient-care reviewers. Designed to serve busy families, working professionals, and underserved communities who often struggle to access reliable, convenient medical care, First Care has become the go-to provider for comprehensive, compassionate, and accessible healthcare across the...

Read more
UPDATE: Dr. Hamid Abbasi to Lead International Spine Surgery Training Programs in Pakistan and the United Arab Emirates
Healthcare & PharmaceuticalCompany Update

UPDATE: Dr. Hamid Abbasi to Lead International Spine Surgery Training Programs in Pakistan and the United Arab Emirates

November 26, 2025 11:45 AM

Dr. Hamid Abbasi, a US-based neurosurgeon and global leader in minimally invasive spine surgery, will travel to Dubai to participate in the World Federation of Neurosurgical Societies WFNS meeting. Dr. Abbasi will conduct hands-on training sessions focused on two advanced techniques: the Oblique Lateral Lumbar Interbody Fusion OLLIF and Sacroiliac Joint SIJ fusion. These procedures are known for reduced surgical trauma, shorter hospital stays,...

Read more
Hospital Executives Signal 2026 as Strategic 'Reset Year'
Healthcare & PharmaceuticalConferences

Hospital Executives Signal 2026 as Strategic 'Reset Year'

November 26, 2025 11:00 AM

As hospitals across the United States navigate another demanding year, a new Thanksgiving week flash survey from Black Book finds hospital executives increasingly viewing 2026 as a strategic "reset year": a period to stabilize finances, solidify leadership teams, and realize the benefits of recent policy and technology investments.In a rapid-response poll of hospital and health system leaders conducted over the past week and weekend, 71% of...

Read more
Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member
Healthcare & PharmaceuticalCompany Update

Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member

November 26, 2025 9:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, has expanded its scientific team with the November 4, 2025 addition of Mark J. Jaroszeski, PhD, a tenured professor in the Department of Medical Engineering at the University of South Florida. Dr. Jaroszeski, who holds a PhD in Engineering Science with a dissertation focused on mechanically...

Read more
Sinceri Senior Living Announces Strategic Expansion & Continued Growth Across Key Markets
Healthcare & PharmaceuticalMergers and Acquisitions

Sinceri Senior Living Announces Strategic Expansion & Continued Growth Across Key Markets

November 26, 2025 9:00 AM

Sinceri Senior Living is pleased to announce the continued expansion of its national foot, print through the transition and management of additional senior living communities across multiple states. The communities are owned by Ventas, Inc., one of the world's preeminent owners of senior housing.This strategic growth reflects Sinceri's commitment to strengthening its presence in key markets, expanding access to its signature care and service...

Read more
Sannabis, Inc. (OTC: USPS) Announces Binational Hemp Block Initiative Designed to Strengthen U.S.-Colombia Relations Through Sustainable Industrial Development
Healthcare & PharmaceuticalCompany Update

Sannabis, Inc. (OTC: USPS) Announces Binational Hemp Block Initiative Designed to Strengthen U.S.-Colombia Relations Through Sustainable Industrial Development

November 26, 2025 8:45 AM

Sannabis, Inc., f/k/a Ultimate Sports, Inc. (OTC:USPS), a U.S. Company (the "Company") planning to acquire Sannabis S.A.S ("Sannabis") in Colombia, is pleased to announce plans to construct two industrial hemp block manufacturing plants-one in Barranquilla, Colombia, and another in Central Georgia, USA-to produce next-generation structural hemp blocks engineered with up to 33+ MPa load-bearing resistance. To the Company's knowledge, no other...

Read more
VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
Healthcare & PharmaceuticalRegulatory

VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

November 26, 2025 8:29 AM

VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine solutions, today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 9,836,065 shares of common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 19,672,130 shares of common stock at an effective combined price of $0.61 per share and common warrant for aggregate...

Read more
Wellgistics Health Announces Sponsorship of Dream Bowl 2026 and Participation in DataVault AI Dream Bowl 2026 Meme Coin Shareholder Distribution Plan
Healthcare & PharmaceuticalCompany Update

Wellgistics Health Announces Sponsorship of Dream Bowl 2026 and Participation in DataVault AI Dream Bowl 2026 Meme Coin Shareholder Distribution Plan

November 26, 2025 7:45 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx™ artificial intelligence prescription routing for the physical dispensing of prescription drugs with PharmacyChain™ blockchain-enabled smart contracts to optimize the tracking, dispending and insurance coverage of prescription pharmaceutical drugs from manufacturer to dispensing from pharmacy to patient, today announced that it...

Read more
DC Healthcare Returns to Profitability with RM3.06 Million PBT in Q3 FY2025
Healthcare & PharmaceuticalCompany Update

DC Healthcare Returns to Profitability with RM3.06 Million PBT in Q3 FY2025

November 25, 2025 11:40 PM

DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), a medical aesthetic services provider specializing in the provision of non-invasive and minimally invasive procedures, delivered a robust performance for the third quarter ended 30 September 2025 ("Q3 FY2025"), achieving a return to profitability with a Profit Before Tax ("PBT") of RM3.06 million for the quarter.The Group posted revenue of RM25.72 million in Q3 FY2025, up 62.7% from...

Read more
CureVac Announces Voting Results of Extraordinary General Meeting
Healthcare & PharmaceuticalShareholder Meeting

CureVac Announces Voting Results of Extraordinary General Meeting

November 25, 2025 7:05 PM

CureVac N.V. (Nasdaq:CVAC)(CureVac or the Company), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), today announced the voting results of its Extraordinary General Meeting (EGM).CureVac's shareholders approved all proposals relating to BioNTech SE's public exchange offer for all outstanding shares in CureVac (Offer) at the EGM with an approval rate of over 99.16% of the...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?